CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MAGIC consortium focuses on developing advanced human models of skeletal muscle diseases to facilitate gene therapy and genome editing for muscular dystrophies. By utilizing innovative technologies, the project aims to create safe and effective treatment vectors for conditions like Duchenne muscular dystrophy and v…
Muscular dystrophies are severe genetic disorders characterised by muscle wasting, impaired mobility and premature death, which to date remain incurable.
Although preclinical and clinical evidence position genetic therapies amongst the key emerging treatments for several genetic conditions, no gene therapy or genome editing strategy has been approved for any muscular dystrophies yet.
The lack of robust, human(ised) models enabling precise development of such advanced therapies is a major barrier…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Hannover
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Creteil
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CHILDREN'S HOSPITAL MEDICAL CENTER
United States, Cincinnati
Type: Research institute
Activity type: Research Organisations
SME: No
Ireland, Maynooth
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
